Journal issue - WANFANG MED ONLINE

You Position: Home > Journal issue

Journal of Leukemia & Lymphoma

Issue 6, 2023

Items 1-5 of 14

«Preious | of 3 | Next»

Clinical application progress of novel targeted drug gilteritinib in treatment of acute myeloid leukemia with FLT3 mutation

Journal of Leukemia and Lymphoma, Volume 32, Issue 6,2023, Pages 377-381, doi:10.3760/cma.j.cn115356-20220916-00261

Investigation and analysis of appetite status in patients with lymphoma during chemotherapy

Journal of Leukemia and Lymphoma, Volume 32, Issue 6,2023, Pages 348-351, doi:10.3760/cma.j.cn115356-20220303-00062

Ibrutinib reduces cytokine release syndrome of CD19 chimeric antigen receptor T-cell for relapsed/refractory mantle cell lymphoma: report of 1 case and review of literature

Journal of Leukemia and Lymphoma, Volume 32, Issue 6,2023, Pages 365-368, doi:10.3760/cma.j.cn115356-20220620-00177

Histiocytic sarcoma of primary lymph node: report of 1 case and review of literature

Journal of Leukemia and Lymphoma, Volume 32, Issue 6,2023, Pages 359-362, doi:10.3760/cma.j.cn115356-20220408-00099

Clinical characteristics of patients with multiple myeloma involving central nervous system

Journal of Leukemia and Lymphoma, Volume 32, Issue 6,2023, Pages 329-334, doi:10.3760/cma.j.cn115356-20221019-00305

Items 1-5 of 14

«Preious | of 3 | Next»

2024:

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

2003:

2002:

2001:

2000: